HCWB (HCW Biologics) Institutional Ownership: 6.91% (As of Jul. 06, 2026)


HCWB HCW Biologics Inc HCWB
39 GF Score
Price $4.68
GF Value $43.78
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is HCW Biologics Institutional Ownership?

HCW Biologics HCWB +8.84% 39 Institutional Ownership is 6.91% as of Jul. 06, 2026. GuruFocus rates HCWB with a GF Score™ of 39/100 and a GF Value™ of $43.78 (Possible Value Trap). The stock has 7 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, HCW Biologics's institutional ownership is 6.91%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, HCW Biologics's Insider Ownership is 54.41%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, HCW Biologics's Float Percentage Of Total Shares Outstanding is 93.75%.

HCW Biologics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for HCW Biologics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HCW Biologics Institutional Ownership Chart

HCW Biologics Historical Data

The historical data trend for HCW Biologics can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 0.52 1.21 1.21 1.05 1.06 1.06 0.27 0.57 1.06 1.06
HCWB
39GF Score
HCW Biologics Inc HCWB
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HCW Biologics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 6.91% mean?
HCW Biologics (HCWB) has a Institutional Ownership of 6.91% as of Jul. 06, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on HCW Biologics and its competitors.
Is HCW Biologics' Institutional Ownership too high?
HCW Biologics' current Institutional Ownership is 6.91%. Overall, HCW Biologics has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does HCW Biologics' Institutional Ownership compare to KAPA and IMNN?
HCW Biologics' Institutional Ownership of 6.91% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on HCW Biologics and its competitors. HCW Biologics's current Institutional Ownership is 6.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCW Biologics stock overvalued right now?
Based on GuruFocus' analysis, HCW Biologics (HCWB) is currently considered Possible Value Trap. The stock's GF Value™ is $43.78, compared to a current price of $4.68 — trading 89.3% below its estimated fair value. The current Institutional Ownership is 6.91%. HCW Biologics' overall GF Score™ is 39/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For HCW Biologics (HCWB), the current Institutional Ownership is 6.91% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HCW Biologics (HCWB) Overvalued in 2026?

Based on GuruFocus' analysis, HCW Biologics stock appears to be undervalued. The current stock price of $4.68 is trading 89.3% below its estimated GF Value™ of $43.78. GuruFocus considers HCW Biologics to be Possible Value Trap.

Key valuation signals for HCWB:

  • Institutional Ownership: 6.91%
  • GF Value™: $43.78 vs. price of $4.68 (89.3% below fair value)
  • GF Score™: 39/100 with 7 warning signs

No single metric tells the full story. See the HCWB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HCW Biologics Business Description

Address 2929 N. Commerce Parkway, Miramar, FL, USA, 33025
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
39GF Score

Get the complete analysis for HCWB

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.68
Price
$43.78
GF Value